CN107334937A - 一种防治抑郁症的保健品的制备方法 - Google Patents
一种防治抑郁症的保健品的制备方法 Download PDFInfo
- Publication number
- CN107334937A CN107334937A CN201710468310.XA CN201710468310A CN107334937A CN 107334937 A CN107334937 A CN 107334937A CN 201710468310 A CN201710468310 A CN 201710468310A CN 107334937 A CN107334937 A CN 107334937A
- Authority
- CN
- China
- Prior art keywords
- parts
- depression
- health products
- preventing
- cordyceps sinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 29
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 22
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 17
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 17
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 17
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 17
- 241001522129 Pinellia Species 0.000 claims abstract description 17
- 241000205407 Polygonum Species 0.000 claims abstract description 17
- 244000292697 Polygonum aviculare Species 0.000 claims abstract description 17
- 235000006386 Polygonum aviculare Nutrition 0.000 claims abstract description 17
- 229920002472 Starch Polymers 0.000 claims abstract description 17
- 241001530209 Swertia Species 0.000 claims abstract description 17
- 235000019698 starch Nutrition 0.000 claims abstract description 17
- 239000008107 starch Substances 0.000 claims abstract description 17
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 16
- 241000733421 Epipactis Species 0.000 claims abstract description 15
- 241000804384 Cynomorium songaricum Species 0.000 claims abstract description 14
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims abstract description 14
- 240000007890 Leonurus cardiaca Species 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 47
- 239000000047 product Substances 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 23
- 239000000341 volatile oil Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 14
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 238000001256 steam distillation Methods 0.000 claims description 10
- 241000207925 Leonurus Species 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 5
- 229920006395 saturated elastomer Polymers 0.000 claims description 5
- 238000010025 steaming Methods 0.000 claims description 5
- 238000001291 vacuum drying Methods 0.000 claims description 5
- 238000009736 wetting Methods 0.000 claims description 5
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 2
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 239000001116 FEMA 4028 Substances 0.000 claims description 2
- 244000082204 Phyllostachys viridis Species 0.000 claims description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 2
- 239000011425 bamboo Substances 0.000 claims description 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 2
- 229960004853 betadex Drugs 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 230000035558 fertility Effects 0.000 abstract description 10
- 210000002216 heart Anatomy 0.000 abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 10
- 210000000952 spleen Anatomy 0.000 abstract description 10
- 238000011282 treatment Methods 0.000 abstract description 10
- 230000002708 enhancing effect Effects 0.000 abstract description 8
- 208000011580 syndromic disease Diseases 0.000 abstract description 6
- 208000031971 Yin Deficiency Diseases 0.000 abstract description 5
- 208000007502 anemia Diseases 0.000 abstract description 5
- 230000001093 anti-cancer Effects 0.000 abstract description 5
- 230000002929 anti-fatigue Effects 0.000 abstract description 5
- 230000007812 deficiency Effects 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 230000007774 longterm Effects 0.000 abstract description 5
- 210000004072 lung Anatomy 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 5
- 230000001151 other effect Effects 0.000 abstract description 5
- 208000020016 psychiatric disease Diseases 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 4
- 239000000935 antidepressant agent Substances 0.000 description 3
- 229940005513 antidepressants Drugs 0.000 description 3
- 230000000994 depressogenic effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 241000554155 Andes Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 229940076279 serotonin Drugs 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 206010061819 Disease recurrence Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000801118 Lepidium Species 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000001970 Raphanus sativus var. sativus Species 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000001671 psychotherapy Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 description 1
- 239000012896 selective serotonin reuptake inhibitor Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/533—Leonurus (motherwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
本申请公开了一种防治抑郁症的保健品的制备方法,称取淀粉、玛卡、虫草、锁阳、益母草、甘草、莲子心、香附、乌金草、夜交藤、野竹兰、山茱萸、半夏、杭白芍和滑石粉;抗疲劳,补充体力,改善睡眠,抗更年期,活跃生育,增强记忆;增强精力、提高生育力、治疗更年期综合症、风湿症、抑郁症、贫血症,疏肝解郁、补虚养脾;药方中各个组分之间产生协同作用,从而带来,抗癌和抗白血病等功效作用,对妇女围绝经期综合症、肝郁气滞、痰气郁结、心脾两虚、肝肾不足和心肺阴虚等导致的抑郁症及更年期综合症具有显著的疗效,无明显毒副作用,长期服用对人体无副作用。
Description
技术领域
本申请属于保健品领域,尤其涉及一种防治抑郁症的保健品的制备方法。
背景技术
抑郁症又称抑郁障碍,以显著而持久的心境低落为主要临床特征,是心境障碍的主要类型。临床可见心境低落与其处境不相称,情绪的消沉可以从闷闷不乐到悲痛欲绝,自卑抑郁,甚至悲观厌世,可有自杀企图或行为;甚至发生木僵;部分病例有明显的焦虑和运动性激越;严重者可出现幻觉、妄想等精神病性症状。每次发作持续至少2周以上、长者甚或数年,多数病例有反复发作的倾向,每次发作大多数可以缓解,部分可有残留症状或转为慢性。
玛卡主要出产于南美洲安第斯山脉和中国云南丽江,是一种十字花科植物。叶子椭圆,根茎形似小圆萝卜,可食用,是一种纯天然食品,营养成份丰富。玛卡的下胚轴可能呈金色或者淡黄色、红色、紫色、蓝色、黑色或者绿色。淡黄色的根最常见,形状、味道也最好。玛卡富含高单位营养素,对人体有滋补强身的功用。黑色玛卡是被公认为效果最好的玛卡,产量极少。玛卡原产高海拔山区,适宜在高海拔、低纬度、高昼夜温差、微酸性砂壤、阳光充足的土地中生长;种植地区主要分布于南美州安第斯山脉以及中国云南丽江的玉龙雪山地区,这两大主产区有较大面积的适种土地。而中国云南其他地区和新疆、西藏等地区也有少量种植。
迄今,抑郁症的病因并不清楚,但可以肯定的是,生物、心理与社会环境诸多方面因素参与了抑郁症的发病过程。生物学因素主要涉及遗传、神经生化、神经内分泌、神经再生等方面;与抑郁症关系密切的心理学易患素质是病前性格特征,如抑郁气质。成年期遭遇应激性的生活事件,是导致出现具有临床意义的抑郁发作的重要触发条件。然而,以上这些因素并不是单独起作用的,目前强调遗传与环境或应激因素之间的交互作用、以及这种交互作用的出现时点在抑郁症发生过程中具有重要的影响。
玛卡属于独行菜属植物,在植物形态特征上与其他独行菜属植物有很多共性。独行菜属植物约175种,全世界有广泛分布;为一年至多年生草本或半灌木,常具单毛、腺毛、柱状毛;茎单一或多数,分枝。叶草质至纸质,线状钻形至宽椭圆形,全缘、锯齿缘至羽状深裂,有叶柄,或基部深心形抱茎。总状花序顶生及腋生;萼片长方形或线状披针形,稍凹,基部不成囊状,具白色或红色边缘;花瓣白色,少数带粉红色或微黄色,线形至匙形,比萼片短,有时退化或不存;雄蕊6个,常退化成2或4个,基部间具微小蜜腺;花柱短或不存,柱头头状,有时稍二裂;子房常有2个胚珠。短角果卵形、倒卵形、圆形或椭圆形,扁平,开裂,有窄隔膜,果瓣有龙骨状突起,或上部梢有翅。种子卵形或椭圆形,无翅或有翅;子叶背倚胚根,很少缘倚胚根。
药物治疗是中度以上抑郁发作的主要治疗措施。目前临床上一线的抗抑郁药主要包括选择性5-羟色胺再摄取抑制剂、5-羟色胺和去甲肾上腺素再摄取抑制剂、去甲肾上腺素和特异性5-羟色胺能抗抑郁药等。传统的三环类、四环类抗抑郁药和单胺氧化酶抑制剂由于不良反应较大,应用明显减少。
有人对抑郁症患者追踪10年的研究发现,有75%~80%的患者多次复发,故抑郁症患者需要进行预防性治疗。发作3次以上应长期治疗,甚至终身服药。维持治疗药物的剂量多数学者认为应与治疗剂量相同,还应定期门诊随访观察。心理治疗和社会支持系统对预防本病复发也有非常重要的作用,应尽可能解除或减轻患者过重的心理负担和压力,帮助患者解决生活和工作中的实际困难及问题,提高患者应对能力,并积极为其创造良好的环境,以防复发。
中国保健品产业经过多年快速发展,已经逐渐壮大。虽然仍面临诸多挑战,但是,中国保健食品产业的发展前景是光明的。在市场需求、技术进步和管理更新的推动下,中国保健品产业发展空间巨大。未来发展将呈现消费者群体多元化、保健品销售模式专营化、宣传模式推陈出新以及保健品成日常消费四大趋势。设计一种安全性高、崩解时间短,分解状态好,易吸收,起效快且没有发现明显的毒副作用的防治抑郁症的保健品的制备方法是非常必要的。
发明内容
解决的技术问题:
本申请针对上述技术问题,提供一种防治抑郁症的保健品的制备方法,解决现有保健品防治抑郁症效果差、崩解时间长和不易吸收等技术问题。
技术方案:
一种防治抑郁症的保健品的制备方法,包括如下步骤:
第一步:按照重量份数配比称取淀粉100份、玛卡25-35份、虫草15-25份、锁阳11-15份、益母草13-15份、甘草5-7份、莲子心1-3份、香附9-11份、乌金草13-15份、夜交藤7-9份、野竹兰6-10份、山茱萸4-8份、半夏6-8份、杭白芍8-10份和滑石粉1-3份;
第二步:将净制、切制后的玛卡和虫草按照2010年版一部中国药典附录IID的蒸法,制成饮片;
第三步:将益母草、莲子心、乌金草、山茱萸、野竹兰、半夏和夜交藤浸泡1.5-3.5小时,加水的量为药材质量的7-9倍量,通过水蒸气蒸馏提取出挥发油,水蒸气蒸馏2-4小时,蒸馏温度为85-95℃,得到的挥发油加挥发油5-7倍质量的β-环糊精,采用饱和水溶液法制备β-环糊精挥发油包合物,包合温度为45-55℃时,搅拌速度为:105-115 r/min,包合40-60min,包合物30-40℃真空干燥后与玛卡饮片和虫草饮片混合均匀;
第四步:再加入甘草、香附、锁阳和杭白芍晒干,粉碎后过100目筛,经乙醇回流提取,过滤,回收乙醇,浓缩得醇提浓缩液,减压浓缩后在80-90℃条件下进行真空干燥,得浸膏干粉,混合均匀后加入淀粉,再加入水润湿后制成混合均匀的稠膏;
第五步:将上述稠膏干燥后粉碎做成颗粒,控制颗粒的水分在3-5%,最后加入滑石粉,混合后压制成片。
作为本发明的一种优选技术方案:所述第四步所加乙醇量是原料药质量的7-9倍量,乙醇体积浓度为80%,分2次回流提取,每次回流80-120min,合并提取液,过滤,滤液减压浓缩回收乙醇,得醇提浓缩液。
作为本发明的一种优选技术方案:所述第一步中防治抑郁症的保健品的原料按重量份数配比如下:淀粉100份、玛卡25份、虫草15份、锁阳11份、益母草13份、甘草5份、莲子心1份、香附9份、乌金草13份、夜交藤7份、野竹兰6份、山茱萸4份、半夏6份、杭白芍8份和滑石粉1份。
作为本发明的一种优选技术方案:所述第一步中防治抑郁症的保健品的原料按重量份数配比如下:淀粉100份、玛卡35份、虫草25份、锁阳15份、益母草15份、甘草7份、莲子心3份、香附11份、乌金草15份、夜交藤9份、野竹兰10份、山茱萸8份、半夏8份、杭白芍10份和滑石粉3份。
作为本发明的一种优选技术方案:所述第一步中防治抑郁症的保健品的原料按重量份数配比如下:淀粉100份、玛卡30份、虫草20份、锁阳13份、益母草14份、甘草6份、莲子心2份、香附10份、乌金草14份、夜交藤8份、野竹兰8份、山茱萸6份、半夏7份、杭白芍9份和滑石粉2份。
有益效果:
本发明所述一种防治抑郁症的保健品的制备方法采用以上技术方案与现有技术相比,具有以下技术效果:1、制备方法简单,成本低廉,配方简单,配伍合理,遵循中医辨证施治的原则,配方各味药相辅相成,具有明显的防治抑郁症的功效,对人体无毒无害,有提高免疫力的保健作用,产品的安全性高;2、抗疲劳,补充体力,改善睡眠,抗更年期,活跃生育,增强记忆;3、增强精力、提高生育力、治疗更年期综合症、风湿症、抑郁症、贫血症,疏肝解郁、补虚养脾;4、药方中各个组分之间产生协同作用,从而带来,抗癌和抗白血病等功效作用,对妇女围绝经期综合症、肝郁气滞、痰气郁结、心脾两虚、肝肾不足和心肺阴虚等导致的抑郁症及更年期综合症具有显著的疗效,无明显毒副作用,长期服用对人体无副作用,可以广泛生产并不断代替现有材料。
具体实施方式
实施例1:
按照重量份数配比称取淀粉100份、玛卡25份、虫草15份、锁阳11份、益母草13份、甘草5份、莲子心1份、香附9份、乌金草13份、夜交藤7份、野竹兰6份、山茱萸4份、半夏6份、杭白芍8份和滑石粉1份。
将净制、切制后的玛卡和虫草按照2010年版一部中国药典附录IID的蒸法,制成饮片。
将益母草、莲子心、乌金草、山茱萸、野竹兰、半夏和夜交藤浸泡1.5小时,加水的量为药材质量的7倍量,通过水蒸气蒸馏提取出挥发油,水蒸气蒸馏2小时,蒸馏温度为85℃,得到的挥发油加挥发油5倍质量的β-环糊精,采用饱和水溶液法制备β-环糊精挥发油包合物,包合温度为45℃时,搅拌速度为:105r/min,包合40min,包合物30℃真空干燥后与玛卡饮片和虫草饮片混合均匀。
再加入甘草、香附、锁阳和杭白芍晒干,粉碎后过100目筛,经乙醇回流提取,过滤,回收乙醇,所加乙醇量是原料药质量的7倍量,乙醇体积浓度为80%,分2次回流提取,每次回流80min,合并提取液,过滤,滤液减压浓缩回收乙醇,浓缩得醇提浓缩液,减压浓缩后在80℃条件下进行真空干燥,得浸膏干粉,混合均匀后加入淀粉,再加入水润湿后制成混合均匀的稠膏。
将上述稠膏干燥后粉碎做成颗粒,控制颗粒的水分在3%,最后加入滑石粉,混合后压制成片。
制备方法简单,成本低廉,配方简单,配伍合理,遵循中医辨证施治的原则,配方各味药相辅相成,具有明显的防治抑郁症的功效,对人体无毒无害,有提高免疫力的保健作用,产品的安全性高;抗疲劳,补充体力,改善睡眠,抗更年期,活跃生育,增强记忆;增强精力、提高生育力、治疗更年期综合症、风湿症、抑郁症、贫血症,疏肝解郁、补虚养脾;药方中各个组分之间产生协同作用,从而带来,抗癌和抗白血病等功效作用,对妇女围绝经期综合症、肝郁气滞、痰气郁结、心脾两虚、肝肾不足和心肺阴虚等导致的抑郁症及更年期综合症具有显著的疗效,无明显毒副作用,长期服用对人体无副作用,可以广泛生产并不断代替现有材料。
实施例2:
按照重量份数配比称取淀粉100份、玛卡35份、虫草25份、锁阳15份、益母草15份、甘草7份、莲子心3份、香附11份、乌金草15份、夜交藤9份、野竹兰10份、山茱萸8份、半夏8份、杭白芍10份和滑石粉3份。
将净制、切制后的玛卡和虫草按照2010年版一部中国药典附录IID的蒸法,制成饮片。
将益母草、莲子心、乌金草、山茱萸、野竹兰、半夏和夜交藤浸泡3.5小时,加水的量为药材质量的9倍量,通过水蒸气蒸馏提取出挥发油,水蒸气蒸馏4小时,蒸馏温度为95℃,得到的挥发油加挥发油7倍质量的β-环糊精,采用饱和水溶液法制备β-环糊精挥发油包合物,包合温度为55℃时,搅拌速度为: 115 r/min,包合60min,包合物40℃真空干燥后与玛卡饮片和虫草饮片混合均匀。
再加入甘草、香附、锁阳和杭白芍晒干,粉碎后过100目筛,经乙醇回流提取,过滤,回收乙醇,所加乙醇量是原料药质量的9倍量,乙醇体积浓度为80%,分2次回流提取,每次回流120min,合并提取液,过滤,滤液减压浓缩回收乙醇,浓缩得醇提浓缩液,减压浓缩后在90℃条件下进行真空干燥,得浸膏干粉,混合均匀后加入淀粉,再加入水润湿后制成混合均匀的稠膏。
将上述稠膏干燥后粉碎做成颗粒,控制颗粒的水分在5%,最后加入滑石粉,混合后压制成片。
制备方法简单,成本低廉,配方简单,配伍合理,遵循中医辨证施治的原则,配方各味药相辅相成,具有明显的防治抑郁症的功效,对人体无毒无害,有提高免疫力的保健作用,产品的安全性高;抗疲劳,补充体力,改善睡眠,抗更年期,活跃生育,增强记忆;增强精力、提高生育力、治疗更年期综合症、风湿症、抑郁症、贫血症,疏肝解郁、补虚养脾;药方中各个组分之间产生协同作用,从而带来,抗癌和抗白血病等功效作用,对妇女围绝经期综合症、肝郁气滞、痰气郁结、心脾两虚、肝肾不足和心肺阴虚等导致的抑郁症及更年期综合症具有显著的疗效,无明显毒副作用,长期服用对人体无副作用,可以广泛生产并不断代替现有材料。
实施例3:
按照重量份数配比称取淀粉100份、玛卡30份、虫草20份、锁阳13份、益母草14份、甘草6份、莲子心2份、香附10份、乌金草14份、夜交藤8份、野竹兰8份、山茱萸6份、半夏7份、杭白芍9份和滑石粉2份。
将净制、切制后的玛卡和虫草按照2010年版一部中国药典附录IID的蒸法,制成饮片。
将益母草、莲子心、乌金草、山茱萸、野竹兰、半夏和夜交藤浸泡2.5小时,加水的量为药材质量的8倍量,通过水蒸气蒸馏提取出挥发油,水蒸气蒸馏2-4小时,蒸馏温度为90℃,得到的挥发油加挥发油6倍质量的β-环糊精,采用饱和水溶液法制备β-环糊精挥发油包合物,包合温度为50℃时,搅拌速度为:110 r/min,包合50min,包合物35℃真空干燥后与玛卡饮片和虫草饮片混合均匀。
再加入甘草、香附、锁阳和杭白芍晒干,粉碎后过100目筛,经乙醇回流提取,过滤,回收乙醇,所加乙醇量是原料药质量的8倍量,乙醇体积浓度为80%,分2次回流提取,每次回流100min,合并提取液,过滤,滤液减压浓缩回收乙醇,浓缩得醇提浓缩液,减压浓缩后在85℃条件下进行真空干燥,得浸膏干粉,混合均匀后加入淀粉,再加入水润湿后制成混合均匀的稠膏。
将上述稠膏干燥后粉碎做成颗粒,控制颗粒的水分在4%,最后加入滑石粉,混合后压制成片。
制备方法简单,成本低廉,配方简单,配伍合理,遵循中医辨证施治的原则,配方各味药相辅相成,具有明显的防治抑郁症的功效,对人体无毒无害,有提高免疫力的保健作用,产品的安全性高;抗疲劳,补充体力,改善睡眠,抗更年期,活跃生育,增强记忆;增强精力、提高生育力、治疗更年期综合症、风湿症、抑郁症、贫血症,疏肝解郁、补虚养脾;药方中各个组分之间产生协同作用,从而带来,抗癌和抗白血病等功效作用,对妇女围绝经期综合症、肝郁气滞、痰气郁结、心脾两虚、肝肾不足和心肺阴虚等导致的抑郁症及更年期综合症具有显著的疗效,无明显毒副作用,长期服用对人体无副作用,可以广泛生产并不断代替现有材料。
以300例抑郁症患者,最大年龄70岁,最小年龄40岁,口服,一日1-3次,一次1-3片,连续需用15天,有效率75.61%,连续服用30天,有效率80.76%,连续服用半年有效率89.41%,连续服用一年,有效率98.42。
以上实施例中的配方所有药材均可以商业购买。
上述实施例只是用于对本发明的内容进行阐述,而不是限制,因此在与本发明的权利要求书相当的含义和范围内的任何改变,都应该认为是包括在权利要求书的范围内。
Claims (5)
1.一种防治抑郁症的保健品的制备方法,其特征在于,包括如下步骤:
第一步:按照重量份数配比称取淀粉100份、玛卡25-35份、虫草15-25份、锁阳11-15份、益母草13-15份、甘草5-7份、莲子心1-3份、香附9-11份、乌金草13-15份、夜交藤7-9份、野竹兰6-10份、山茱萸4-8份、半夏6-8份、杭白芍8-10份和滑石粉1-3份;
第二步:将净制、切制后的玛卡和虫草按照2010年版一部中国药典附录IID的蒸法,制成饮片;
第三步:将益母草、莲子心、乌金草、山茱萸、野竹兰、半夏和夜交藤浸泡1.5-3.5小时,加水的量为药材质量的7-9倍量,通过水蒸气蒸馏提取出挥发油,水蒸气蒸馏2-4小时,蒸馏温度为85-95℃,得到的挥发油加挥发油5-7倍质量的β-环糊精,采用饱和水溶液法制备β-环糊精挥发油包合物,包合温度为45-55℃时,搅拌速度为:105-115 r/min,包合40-60min,包合物30-40℃真空干燥后与玛卡饮片和虫草饮片混合均匀;
第四步:再加入甘草、香附、锁阳和杭白芍晒干,粉碎后过100目筛,经乙醇回流提取,过滤,回收乙醇,浓缩得醇提浓缩液,减压浓缩后在80-90℃条件下进行真空干燥,得浸膏干粉,混合均匀后加入淀粉,再加入水润湿后制成混合均匀的稠膏;
第五步:将上述稠膏干燥后粉碎做成颗粒,控制颗粒的水分在3-5%,最后加入滑石粉,混合后压制成片。
2.根据权利要求1所述的一种防治抑郁症的保健品的制备方法,其特征在于:所述第四步所加乙醇量是原料药质量的7-9倍量,乙醇体积浓度为80%,分2次回流提取,每次回流80-120min,合并提取液,过滤,滤液减压浓缩回收乙醇,得醇提浓缩液。
3.根据权利要求1所述的一种防治抑郁症的保健品的制备方法,其特征在于:所述第一步中防治抑郁症的保健品的原料按重量份数配比如下:淀粉100份、玛卡25份、虫草15份、锁阳11份、益母草13份、甘草5份、莲子心1份、香附9份、乌金草13份、夜交藤7份、野竹兰6份、山茱萸4份、半夏6份、杭白芍8份和滑石粉1份。
4.根据权利要求1所述的一种防治抑郁症的保健品的制备方法,其特征在于:所述第一步中防治抑郁症的保健品的原料按重量份数配比如下:淀粉100份、玛卡35份、虫草25份、锁阳15份、益母草15份、甘草7份、莲子心3份、香附11份、乌金草15份、夜交藤9份、野竹兰10份、山茱萸8份、半夏8份、杭白芍10份和滑石粉3份。
5.根据权利要求1所述的一种防治抑郁症的保健品的制备方法,其特征在于:所述第一步中防治抑郁症的保健品的原料按重量份数配比如下:淀粉100份、玛卡30份、虫草20份、锁阳13份、益母草14份、甘草6份、莲子心2份、香附10份、乌金草14份、夜交藤8份、野竹兰8份、山茱萸6份、半夏7份、杭白芍9份和滑石粉2份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710468310.XA CN107334937A (zh) | 2017-06-20 | 2017-06-20 | 一种防治抑郁症的保健品的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710468310.XA CN107334937A (zh) | 2017-06-20 | 2017-06-20 | 一种防治抑郁症的保健品的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107334937A true CN107334937A (zh) | 2017-11-10 |
Family
ID=60221452
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710468310.XA Pending CN107334937A (zh) | 2017-06-20 | 2017-06-20 | 一种防治抑郁症的保健品的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107334937A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109223978A (zh) * | 2017-07-10 | 2019-01-18 | 绫充匠 | 一种产后抑郁症的治疗药物 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101168024A (zh) * | 2007-10-25 | 2008-04-30 | 陈卫辉 | 一种治疗抑郁症的中成药及其生产方法 |
CN102258742A (zh) * | 2010-05-27 | 2011-11-30 | 倪健 | 一种治疗抑郁症的中药组合物及其制备方法 |
-
2017
- 2017-06-20 CN CN201710468310.XA patent/CN107334937A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101168024A (zh) * | 2007-10-25 | 2008-04-30 | 陈卫辉 | 一种治疗抑郁症的中成药及其生产方法 |
CN102258742A (zh) * | 2010-05-27 | 2011-11-30 | 倪健 | 一种治疗抑郁症的中药组合物及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109223978A (zh) * | 2017-07-10 | 2019-01-18 | 绫充匠 | 一种产后抑郁症的治疗药物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101906376B (zh) | 一种保健醋 | |
CN107303384A (zh) | 一种对多种症状具有疗效的中药组合物及其衍生物和制品 | |
CN103382431B (zh) | 一种中草药十八子保健酒及其制备方法 | |
CN102845745A (zh) | 一种铁皮石斛保健品 | |
CN101884422A (zh) | 多元素中药保健饮品 | |
CN105614678A (zh) | 一种富硒海蓬子营养保健面条及其生产工艺 | |
CN1676036B (zh) | 灵芝金刚根保健食品及其制备方法 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN103355619B (zh) | 一种滇橄榄葛根保健食品 | |
CN104666928A (zh) | 一种铁皮石斛菊花快速饮片制备方法 | |
CN107334937A (zh) | 一种防治抑郁症的保健品的制备方法 | |
CN102698099B (zh) | 一种治疗糖尿病的丸剂 | |
CN105031030A (zh) | 一种红豆杉果酒及其制作方法 | |
CN108837101A (zh) | 一种治疗失眠的中药膏方及制备方法 | |
CN104222373A (zh) | 一种黄精保健茶及其制备方法 | |
CN101455374B (zh) | 一种具有补血养心作用的保健品及其制备方法 | |
CN104056144A (zh) | 治疗阴虚咳嗽的中药制剂 | |
CN107361357A (zh) | 一种抗癌的保健品的制备方法 | |
CN107348495A (zh) | 一种增强精力的保健品的制备方法 | |
CN107334933A (zh) | 一种补肾壮阳的保健品的制备方法 | |
CN105192209A (zh) | 一种丹参叶软化血管保健茶及其制备方法 | |
CN107684574A (zh) | 具有降血脂功能的药食两用组合物及其制备方法 | |
CN106421469A (zh) | 一种治疗白发的中药组合物 | |
CN105054196A (zh) | 一种具有延缓衰老功效的玫瑰花海洋功能性保健饮料 | |
CN105031174A (zh) | 一种具有补肝益肾功效的营养保健面条及生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20171110 |
|
RJ01 | Rejection of invention patent application after publication |